Biotech Business Week articles from September 2003

Biotech Business Week archives from September 2003

First component of rolling NDA submitted for RSR13.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that it has begun submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for the company's investigational radiation...

Research alliance centers on monoclonal antibody for inflammatory disease.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories and LigoCyte Pharmaceuticals, Inc., announced a research collaboration on an anti-inflammatory monoclonal antibody for the treatment of inflammatory diseases. The collaboration...

Data show Enterra therapy reduces persistent nausea, vomiting.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- According to newly reported research in Gastroenterology, high-frequency, low-energy gastric electrical stimulation (GES) of the stomach with Enterra Therapy from Medtronic, Inc., (MDT) reduces many of...

Human Genome Sciences announces license agreement.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced a license agreement with Genentech, Inc., (DNA). Under this agreement, Genentech has acquired exclusive, worldwide patent rights to develop and...

Phase I clinical testing of ACP-103 complete.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Acadia Pharmaceuticals has successfully completed phase I clinical testing of ACP-103, the company's proprietary small molecule 5-HT2A inverse agonist. The study was designed to evaluate the...

Early-stage pharmaceuticals: R&D spending doubles, NDAs plummet.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- New drug approvals have plummeted from 53 new molecular entities approved in 1996 to just 26 in 2002; at the same time, R&D spending has nearly doubled from $17 billion in 1996 to $32 billion last year,...

Polyethylene glycol FGF2 conjugates retarget adenoviruses to select domains.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Polyethylene glycol FGF2 conjugates retarget adenoviruses to select domains. According to published research from the United States, "bifunctional PEG (polyethylene glycol) molecules provide a novel...

Patient enrollment completed in phase IIb CART-2 study with AGI-1067.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) has recently completed enrollment in a phase IIb clinical trial evaluating its proprietary v-protectant drug candidate, AGI-1067, as a treatment for atherosclerosis and...

FDA approves Photofrin for the ablation of high-grade dysplasia.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., announced that it has received approval from the U.S Food and Drug Administration (FDA) for the use of Photofrin photodynamic therapy (PDT) in the ablation of high-grade dysplasia...

Trial tests treatment for postmenopausal cancer patients who relapse.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that patient recruitment has begun on an important new trial involving its novel estrogen receptor antagonist, "Faslodex" (fulvestrant). The trial, called EFECT, is designed...

$50,000 development grant will support Oregon's bioscience industry.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The Oregon Bioscience Association (OBA) announced a partnership between the association and the Oregon Economic and Community Development Department (OECDD), a state organization whose mission is to...

Liposome technology company initiates cooperative alliance.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- CytoGenix, Inc., (CYGX) has completed an agreement with BioZone Laboratories, Inc., of Pittsburg, California, to investigate the synergy of their technologies to develop and test new formulations for...

Partners HealthCare enters clinical research alliance.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Guava Technologies, Inc., a company focused on changing the way that cell analysis is performed, and Partners HealthCare, an integrated healthcare delivery system, announced that they have formed a...

Chemistry-driven drug discovery company realigns business mission.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- In a further step to continually adapt its organization and technology platform to best meet the needs of the pharmaceutical industry, ChemCodes is accelerating its plans for internal compound...

Contract signed for exclusive provider for MRI magnet base.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Air Products announced that its KeepCOLD Cryogenic Fill Services Program will be the exclusive cryogenic provider for Siemens Medical Systems' entire United States magnetic resonance imaging (MRI)...

Improved single nucleotide polymorphism-based genotype assays developed.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- A series of improved single nucleotide polymorphism (SNP)-based genotype assays have been developed. Scientists in California described "a new mechanism for allelic discrimination - allele-specific...

Reduction in work force announced at lab-on-a-chip company.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Caliper Technologies Corp. (CALP) announced that it is reducing its work force by approximately 50 positions, or 9% of its total head count. The reduction is part of ongoing integration efforts...

Agreement signed for use of chemical assay.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Avitar, Inc., (AVR) announced that it has signed a Letter of Understanding with Immunomatrix, Inc., for the exclusive right to utilize Immunomatrix's high sensitivity chemical assay technologies in...

Pharmaceutical firm to help state AIDS programs.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) announced an agreement with the state-administered AIDS Drug Assistance Programs (ADAPs) to provide interim emergency relief to help address the funding crisis facing...

Inpharmatica secures ADME service agreement with European pharmaceutical company.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Inpharmatica, Ltd., an informatics-driven drug discovery company, announced that it has entered into a nonexclusive ADME service agreement with Ionix Pharmaceuticals, Ltd., a European analgesic drug...

Disaster relief fund in jeopardy.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Over the past year, the American Red Cross spent $114.3 million from its Disaster Relief Fund to provide assistance to victims of more than 3,300 disasters throughout the United States and its...

FDA eliminates current label requirement on snack foods made with Olean.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The Procter & Gamble Co. (PG) announced that the U.S. Food and Drug Administration (FDA) has eliminated the label requirement for packages of snack foods made with the company's Olean fat replacer. ...

ADHD drug maker reports earnings of $0.31 per share.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Cephalon, Inc., (CEPH) reported results for the second quarter of 2003, which included total revenue of $168.8 million, product sales of $160.3 million, and diluted earnings per share of $0.31. ...

APF112 phase II submitted for FDA review; royalty income increases 11%.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- A.P. Pharma, Inc., (APPA) reported financial results for the 3 months ended June 30, 2003, reflecting increased royalty income and contract revenues as well as higher research and development expenses...

Allergan collaboration leads to increased revenues for pharmaceutical company.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Inspire Pharmaceuticals, Inc., (ISPH) reported financial results for the second quarter ended June 30, 2003. For the quarter ended June 30, 2003, the company reported a net loss of $6.6 million, or...

Biosurgical device company reports net loss of $22.3M.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc., (CRY) reported financial results for the second quarter 2003. Revenues for the second quarter 2003 were $15.7 million compared to $23.3 million in the second quarter 2002. Net loss...

Biotech company reports $0.36 per share loss.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) reported financial results for the 3- and 6-month periods ended June 30, 2003. For the 3 months ended June 30, 2003, the company reported a net loss of $11.5 million or...

Biotherapeutics company reports loss of $0.24 per share.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Applied Molecular Evolution, Inc., (AME, AMEV) reported financial results for the second quarter of 2003. For the quarter ended June 30, 2003, the company reported a net loss of $5.0 million or...

Board authorizes $1B share-repurchase program at medical products firm.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The board of directors of Cardinal Health, Inc., (CAH) authorized the purchase by Cardinal Health of up to $1 billion of its common shares. The share-repurchase authorization permits the company to...

Body monitoring device company raises $4M.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- BodyMedia announced the closing of a $4 million series C preferred stock financing round. The round was led by Draper Fisher Jurvertson ePlanet and Draper Triangle Ventures; Saturn Partners and the...

Cell imaging systems provider secures equipment financing line.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- ChromaVision Medical Systems, Inc., (CVSN), a provider of automated cell-imaging systems and manufacturer of the ACIS digital microscope system, announced that it has entered into an agreement for a...

Corvas acquisition helps strengthen company's second quarter.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Dendreon Corp. (DNDN) reported results for the quarter ended June 30, 2003, and provided an overview of recent company achievements. Revenues for the second quarter of 2003 were $1.8 million...

Device company reports 129% increase in net income.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Arrhythmia Research Technology, Inc., (HRT) and it's wholly owned subsidiary Micron Products, Inc., (Micron) reported total revenue of $1,940,000 and net income of $285,000 for the second quarter of...

Dialysis company reports net loss of $0.19 per share.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Aksys, Ltd., (AKSY) reported results for the quarter ended June 30, 2003. For the second quarter of 2003, Aksys reported total revenues of $301,000 compared to no revenue for the second quarter of...

Drug delivery company reports $0.47 per share loss.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Alkermes, Inc., (ALKS) reported its financial results for the 3-month period ended June 30, 2003. The net loss on a GAAP basis for the quarter ended June 30, 2003, was $30.6 million or $0.47 per...

Drug discovery firm meets analysts' estimate for revenues, earnings.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the fourth quarter and full year of fiscal 2003, ended June 30, 2003. During the fourth quarter of fiscal 2003, Array reported total...

Epilepsy device maker reports 16% increase in sales.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Cyberonics, Inc., (CYBX) announced financial results for the first quarter ended July 25, 2003, of its fiscal year ending April 30, 2004. Net sales increased $3.6 million (16%) to $26.7 million...

Genomics technology company provides update on its second quarter.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO), a provider of products that accelerate genomic analysis, reported revenues for the second quarter of $2.5 million compared to $2.5 million in the like period in 2002....

Heart valve company raises $12.3M in private placement of common stock.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Michael D. Dale, president and CEO of ATS Medical, Inc., (ATSI) announced the execution of agreements to sell 4.4 million shares of common stock for gross proceeds of $12.3 million in a private...

Hormone therapy company raises $10.3M in private placement.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has raised $10.3 million through the private placement of approximately 4.8 million newly issued shares of BioSante common stock to several new...

Immunology company reports financial results, discusses Aventis collaboration.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- ImmunoGen, Inc., (IMGN) announced financial results for the 3- and 12-month periods ended June 30, 2003. For the 3-month period, the company reported a net loss of $6.9 million, or $0.17 per basic...

Oncology drug maker reports 66% increase in revenue.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Aeterna Laboratories, Inc., (AEL; AELA) reported total revenues for the second quarter ended June 30, 2003, of $38.9 million, an increase of 66% compared with total revenues of $23.4 million for the...

Pharmaceutical company reports net loss of $0.01 per share.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- AutoImmune, Inc., (AIMM) reported a net loss of $0.14 million, or $0.01 per share basic and diluted, for the 3 months ended June 30, 2003, compared with a net loss of $0.18 million, or $0.01 per share...

Pharmaceutical distributor reports earnings of $0.29 per share.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- D&K Healthcare Resources, Inc., (DKHR) reported diluted earnings per share (EPS) of $0.29 on net income of $4.2 million for the fourth quarter fiscal 2003 ended June 30, 2003. The results compare...

Pharmaceutical firm reports earnings of $2.43 per share.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) reported revenues of $902.9 million and net earnings of $167.6 million, or $2.43 per fully diluted share for its fiscal year ended June 30, 2003, which included charges of...

Pharmaceutical firm reports loss of $0.14 per share.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced financial results for its second quarter ended June 30, 2003. The net loss was $9.1 million ($0.14 per share) for the second quarter of 2003 compared...

Pneumo Sleeve maker reports second quarter loss of $536,000.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Dexterity Surgical, Inc., (DEXT) announced results of operations for the second quarter ended June 30, 2003. The company reported a second quarter 2003 net loss applicable to common stock of...

Pulsatile drug company files with SEC for IPO.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Advancis Pharmaceutical Corporation announced that it filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering (IPO) of its common stock....

Ribapharm parent reports second quarter 2003 net income of $14.9 million.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- ICN Pharmaceuticals, Inc., (ICN) announced second quarter 2003 revenues of $183.5 million, compared with $180.8 million in the same period last year. ICN also reported net income for the 2003 second...

Rosacea drug maker increases guidance for 2003.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BDY) released guidance for estimated net sales and earnings per share for the year 2003. These projections represent an increase over the previous guidance set on...

Status of stock offering reported by laser company.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Biolase Technology, Inc., (BLTI) announced that it and its independent accountants have decided to seek guidance from the U.S. Securities and Exchange Commission (SEC) regarding the accounting affect of...

Stock split declared by pharmaceutical firm in form of dividend.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX, APP) announced that its board of directors has declared a three for two stock split in the form of a stock dividend. The stock dividend will be paid...

Venture capital group invests in chloroplast DNA company.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Harris & Harris Group, Inc., announced it has invested $525,900 as part of a convertible preferred financing of privately held Chlorogen, Inc. Investors in this financing include Burrill & Co.,...

Women's health drug maker reports loss of $0.12 per share.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Columbia Laboratories (COB) announced financial results for the second quarter and 6 months ended June 30, 2003. For the second quarter of 2003, the company reported a loss of $4,366,608, or $0.12...

Series B financing raises $26.4M to fund infectious disease program.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- ActivBiotics, Inc., announced an initial closing of $26.4 million on its Series B round of financing. MDS Capital Corp. led the funding round that included other new investors BioVentures...

BlockAide trial to begin in fourth quarter; scientific advisory board formed.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Adventrx Pharmaceuticals, Inc., (AVRX) announced the formation of its new scientific advisory board, consisting of three well-known academic experts in the areas of anticancer and antiviral development....

PMA approval granted for ProCol vascular bioprosthesis.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Hancock Jaffe Laboratories, Inc., announced it has received U.S. Food and Drug Administration (FDA) approval to market the ProCol vascular bioprosthesis for hemodialysis access in the United States. The...

Cardius-1, upgradable single-head gamma camera, released.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Digirad Corp., a solid-state gamma camera technology company and nuclear imaging services provider, announced the release of its upgradable nuclear gamma camera available. Cardius-1 is a...

Patent granted for ISA247, a calcineurin inhibitor.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Isotechnika, Inc., has received an issue notification from the United States Patent and Trademark Office regarding its immunosuppressive compound ISA247. This application has been issued United...

Gilead inks nonexclusive HCV licensing agreement, initiate research programs.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Gilead Sciences, Inc., (GILD) announced that it has entered into a nonexclusive licensing agreement with Chiron Corp. for the research, development, and commercialization of small molecule therapeutics...

Doctors Laboratory to offer VAP expanded cholesterol test.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Doctors Laboratory, Inc., will offer the next-generation VAP (Vertical Auto Profile) Cholesterol Test as part of its expansive menu of diagnostic services. The VAP Test, developed by Birmingham,...

Burn injury management product sales will double.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Burn injury management products will show double-digit gains in the coming years, according to a new study released by Kalorama Information. Although only one part of the approximately $1.5 billion...

Coronary heart disease market to reach $23B in 2012.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., a research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the total market value of drugs to treat coronary heart disease (CHD) could reach...

FTC clears Biogen merger.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- IDEC Pharmaceuticals Corp. (IDPH) and Biogen, Inc., (BGEN) announced that the Federal Trade Commission has completed its review of their proposed merger and granted early termination of the waiting...

Genesis Bioventures announces merger.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Genesis Bioventures, Inc., (GBI) announced the signing of a formal letter of intent to merge with Corgenix Medical Corp. (CONX) of Denver, Colorado. Under the terms of the letter of intent, Genesis...

Letter of intent signed for merger with diagnostics company.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Corgenix Medical Corporation (CONX) announced that it has signed a letter of intent to merge with Genesis Bioventures, Inc., (GBI) a biomedical development company focused on the development of...

Pharmaceutical research company buys Clinical Pharmacology Associates.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- SFBC International, Inc., (SFCC) has completed the acquisition of Clinical Pharmacology Associates (CP), based in Miami, Florida. The agreement provides for the acquisition of CP for approximately...

Big pharma orders make for successful commercial launch for Dynaflow.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The Swedish biotech tools company Cellectricon has received orders from three of the top five pharmaceutical companies. The orders verify that major pharmaceutical companies will adopt the Dynaflow...

First Flexogan order delivered to Canadian retailer.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- AlphaRx, Inc., (ALRX) announced their first product delivery. Flexogan, AlphaRx's topical pain reliever, has been delivered to Loblaw Companies Limited, a mass market retailer in Canada. Flexogan,...

Anderson joins scientific advisory board at cancer drug firm.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Callisto Pharmaceuticals, Inc., (CLSP) announced that Kenneth C. Anderson, director of the Jerome Lipper Multiple Myeloma Center of the Dana-Farber Cancer Institute and professor of medicine at Harvard...

Durrant named president of pediatric drug firm.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- The board of directors of PediaMed Pharmaceuticals, Inc., announced the appointment of Cameron Durrant, MD, as president. He will be reporting to and sitting on the board of PediaMed. A...

Martone appointed head of medical affairs at pharmaceutical firm.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) announced the appointment of William J. Martone, MD, as executive director, medical affairs. The company also announced that it has hired the first of three...

Physicians using online marketing content, spending less time with sales reps.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- As the number of pharmaceutical sales representatives has almost doubled in the last 5 years, so has the competition to spend time with the most valuable physicians, those writing a high volume of...

FDA gives green light to U.S. phase I clinical trials for Psoraxine.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Astralis, Ltd., (ASTR) announced that the U.S. Food and Drug Administration (FDA) has allowed the company to start phase I clinical trials in the U.S. for Psoraxine for the treatment of moderate to...

MRI pharmaceutical company announces pricing of 4,300,000 shares of common stock.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- EPIX Medical, Inc., (EPIX), a developer of specialty pharmaceuticals for magnetic resonance imaging (MRI), announced that it has priced its previously announced public offering of 4,300,000 newly issued...

PET equipment supplier comments on proposed APC rates for 2004.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- CTI Molecular Imaging, Inc., (CTMI), a provider of positron emission tomography (PET) equipment, molecular probes, and services, commented on the announcement by the U.S. Centers for Medicare and...

Happy Valley Medical strikes deal to evaluate Ceracor.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Happy Valley Medical, Inc., announced that it has entered into a research alliance with Edwards Lifesciences Corp. (EW) to evaluate the antiproliferative and antirestenotic properties of C6-ceramide in...

Novel microscope slide adhesive for poorly adherent tissue sections is developed.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Novel microscope slide adhesive for poorly adherent tissue sections is developed. "We describe a protected isocyanate (PI) microscope slide-coating technology that significantly enhances tissue...

Biotech firm reports conditional continued listing on NASDAQ SmallCap.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- BioSpecifics Technologies Corp. (BSTCE) has been notified by The NASDAQ Stock Market that the NASDAQ Listing Qualifications Panel has determined to continue the listing of the company's common stock on...

Infectious disease-focused company approved for AMEX.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Immtech International, Inc., (IMM) announced its common stock has been approved for listing on the American Stock Exchange (AMEX). Immtech is expected to have Bear Wagner Specialists, LLC, as the...

Biopharmaceutical company raises $2.7 million in private placement financing.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Genelabs Technologies, Inc., (GNLB) announced that it has completed the sale of 1,666,667 shares of its common stock to one institutional investor at a price of $1.595 per share, for gross proceeds of...

Devices and prescription drugs driving growth in U.S. pain management market.
September 1, 2003... 2003 SEP 1 - (NewsRx.com & NewsRx.net) -- Medtech Insight, LLC, in its newly published "Pharmacological and Device-Based Therapeutic Approaches to Pain Management," addresses how devices and prescription medications are driving the U.S. pain...

Bioanalytical devices company introduces multidetection system.
September 8, 2003... 2003 SEP 8 - (NewsRx.com & NewsRx.net) -- Molecular Devices Corporation (MDCC) announced the introduction of SpectraMax M2, the first dual-monochromator, multidetection microplate reader with dual-mode cuvette port for fluorescence and...

Collaboration targets development of RC-529 adjuvant.
September 8, 2003... 2003 SEP 8 - (NewsRx.com & NewsRx.net) -- Corixa Corp. (CRXA) and Apovia AG announced a research, development, and commercialization agreement for Corixa's synthetic adjuvant, RC-529. The multiyear agreement grants Apovia commercial rights...